Antinuclear Antibody Test Market Players:
- F. Hoffmann-La Roche Ltd.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- ERBA Diagnostics, Inc.
- Zeus Scientific Inc.
- Trinity Biotech plc
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- Immuno Concepts Inc.
- Euroimmun Medizinische Labordiagnostika AG
- Antibodies Incorporated
- Becton, Dickinson and Company
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of antinuclear antibody test is evaluated at USD 2.11 billion.
The global antinuclear antibody test market size was worth over USD 1.88 billion in 2025 and is poised to grow at a CAGR of around 13.3%, reaching USD 6.55 billion revenue by 2035.
North America antinuclear antibody test market will dominate over 40.6% share by 2035, fueled by rising autoimmune disease prevalence and aging population.
Key players in the market include F. Hoffmann-La Roche Ltd., ERBA Diagnostics, Inc., Zeus Scientific Inc., Trinity Biotech plc, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Immuno Concepts Inc., Euroimmun Medizinische Labordiagnostika AG, Antibodies Incorporated, Becton, Dickinson and Company.
